Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity …
AH Wei, L Zeng, L Wang, L Gui, WT Zhang… - Frontiers in …, 2023 - frontiersin.org
Background: Nirmatrelvir/ritonavir and azvudine have been approved for the early treatment
of COVID-19 in China, however, limited real-world data exists regarding their effectiveness …
of COVID-19 in China, however, limited real-world data exists regarding their effectiveness …
[HTML][HTML] COVID-19: On the threshold of the fifth year. The situation in Spain
F Rodríguez-Artalejo, J Ruiz-Galiana… - Revista Española de …, 2024 - ncbi.nlm.nih.gov
Despite having emerged from pandemic status, the incidence of COVID-19 episodes has
recently increased in Spain, including pediatric cases and admissions to Intensive Care …
recently increased in Spain, including pediatric cases and admissions to Intensive Care …